Literature DB >> 26071054

Toll-like receptor 4-induced inflammatory responses contribute to the tumor-associated macrophages formation and infiltration in patients with diffuse large B-cell lymphoma.

Xiaofang Wang1, Xiangli Li2, Xiaoying Zhang2, Li Zang2, Hongliang Yang2, Weipeng Zhao2, Haifeng Zhao2, Qian Li2, Bing Xia2, Yong Yu2, Yafei Wang2, Zhigang Zhao2, Yizhuo Zhang2.   

Abstract

To evaluate the expression of tumor-associated macrophages (TAMs) and Toll-like receptor 4 (TLR4) in diffuse large B-cell lymphoma (DLBCL) and their correlation with patient clinical characteristics, we detected using immunohistochemistry in 81 specimens of patients with DLBCL. The correlation between protein expression levels and clinical parameters, as well as the association between CD68 and TLR4 were analyzed. The number of CD68 TAMs was closely related to β2-microglobulin (P = .028 and P < .05), whereas there was no significant correlation between the number of CD68 TAMs and other clinical factors. Toll-like receptor 4 was related to tumor size and peripheral blood lymphocyte to monocyte ratio. The Spearman correlation coefficient indicated a significant positive correlation between CD68 TAMs and TLR4 expression (r = 0.240; P = .038, P = .05). These results, on one hand, indicated that TLR4-induced inflammatory responses may affect TAM infiltration and accumulation, and that TAMs and TLR4 may interact to play important roles in DLBCL microenvironment regulating the tumor growth, but, on the other hand demonstrated that both of TAMs and TLR4 had not only one side on DLBCL growth.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Clinical parameters; Diffuse large B-cell lymphoma (DLBCL); Immunohistochemistry; Toll-like receptor 4 (TLR4); Tumor-associated macrophages (TAMs)

Mesh:

Substances:

Year:  2015        PMID: 26071054     DOI: 10.1016/j.anndiagpath.2015.04.008

Source DB:  PubMed          Journal:  Ann Diagn Pathol        ISSN: 1092-9134            Impact factor:   2.090


  5 in total

Review 1.  Recent advances in cancer immunotherapy: Modulation of tumor microenvironment by Toll-like receptor ligands.

Authors:  Leila Rostamizadeh; Ommoleila Molavi; Mohsen Rashid; Fatemeh Ramazani; Behzad Baradaran; Afsaneh Lavasanaifar; Raymond Lai
Journal:  Bioimpacts       Date:  2022-03-26

2.  Elevated expression of pancreatic adenocarcinoma upregulated factor (PAUF) is associated with poor prognosis and chemoresistance in epithelial ovarian cancer.

Authors:  Chel Hun Choi; Tae Heung Kang; Joon Seon Song; Young Seob Kim; Eun Joo Chung; Kris Ylaya; Seokho Kim; Sang Seok Koh; Joon-Yong Chung; Jae-Hoon Kim; Stephen M Hewitt
Journal:  Sci Rep       Date:  2018-08-15       Impact factor: 4.379

3.  Drinking Hydrogen-Rich Water Alleviates Chemotherapy-Induced Neuropathic Pain Through the Regulation of Gut Microbiota.

Authors:  Naqi Lian; Mengxi Shen; Kai Zhang; Jiacheng Pan; Yi Jiang; Yang Yu; Yonghao Yu
Journal:  J Pain Res       Date:  2021-03-10       Impact factor: 3.133

4.  M2 tumour-associated macrophages contribute to tumour progression via legumain remodelling the extracellular matrix in diffuse large B cell lymphoma.

Authors:  Long Shen; Honghao Li; Yuzhi Shi; Dekun Wang; Junbo Gong; Jing Xun; Sifan Zhou; Rong Xiang; Xiaoyue Tan
Journal:  Sci Rep       Date:  2016-07-28       Impact factor: 4.379

Review 5.  The role of toll-like receptor 4 in tumor microenvironment.

Authors:  Jing Li; Fan Yang; Feng Wei; Xiubao Ren
Journal:  Oncotarget       Date:  2017-07-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.